Low-Dose Decitabine-Based Chemoimmunotherapy for Patients with Refractory Advanced Solid Tumors: A Phase I/II Report
Figure 2
Trial profile. () Reasons for not meeting the inclusion criteria: patient had a massive hemorrhage (). CIK: cytokine induced killer cells. DAC + Chemo: DAC combined with chemotherapy group; DAC + CIK: DAC combined with CIK group.
